Oliveira-Cunha Melissa, Dennison Ashley R, Garcea Giuseppe
Department of Hepatobiliary and Pancreatic Surgery, University Hospitals of Leicester, NHS Trust, Leicester, UK.
Surg Laparosc Endosc Percutan Tech. 2016 Feb;26(1):1-5. doi: 10.1097/SLE.0000000000000226.
The introduction of endoscopic retrograde cholangiopancreatography with endoscopic sphincterotomy (ES) has changed the treatment of choledocholithiasis. An increasing number of young patients are requiring ES, and this raises concern regarding any potential long-term complications arising from irreversibly altering the anatomy of the sphincter of Oddi. In particular, concern has been raised regarding the risk of late cholangiocarcioma. A review was performed evaluating the relationship between ES for benign disease and the subsequent development of late complications, including biliary tract malignancy, the formation of primary duct stones, and recurring cholangitis. A systematic review of articles published between 1970 and 2013 was undertaken. Current evidence shows that ES is a safe and effective treatment for common bile duct stones. The long-term risk of subsequent cholangiocarcinoma has not been convincingly proven although in many of these studies the follow-up period was inadequate. There does appear to be an associated increased incidence of cholangiocarcinomas following sphincterotomy although this is not proven to be causative. If there is an increased risk of cholangiocarcinoma following ES, it is likely to be small in western populations. However, until longer follow-up studies are published, it may be prudent to avoid ES in the very young.
内镜逆行胰胆管造影术联合内镜括约肌切开术(ES)的引入改变了胆总管结石的治疗方式。越来越多的年轻患者需要接受ES治疗,这引发了人们对于因不可逆地改变Oddi括约肌解剖结构而产生的任何潜在长期并发症的担忧。特别是,人们对晚期胆管癌的风险提出了关注。我们进行了一项综述,评估针对良性疾病的ES与后续晚期并发症(包括胆道恶性肿瘤、原发性胆管结石形成和复发性胆管炎)发生之间的关系。我们对1970年至2013年间发表的文章进行了系统综述。目前的证据表明,ES是治疗胆总管结石的一种安全有效的方法。尽管在许多此类研究中随访期不足,但后续胆管癌的长期风险尚未得到令人信服的证实。括约肌切开术后胆管癌的发病率确实似乎有所增加,尽管这尚未被证明具有因果关系。如果ES术后胆管癌风险增加,在西方人群中可能很小。然而,在发表更长随访期的研究之前,对于非常年轻的患者避免进行ES可能是谨慎之举。